455 related articles for article (PubMed ID: 2125401)
1. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D in Paget's disease of bone.
Foldes J; Shamir S; Kidroni G; Menczel J
Clin Orthop Relat Res; 1989 Jun; (243):275-9. PubMed ID: 2498022
[TBL] [Abstract][Full Text] [Related]
3. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone.
Castro-Errecaborde N; de la Piedra C; Rapado A; Alvarez-Arroyo MV; Torres R; Traba ML
J Clin Endocrinol Metab; 1991 Feb; 72(2):462-6. PubMed ID: 1991815
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D status in Paget's bone disease. Effects of calcitonin therapy.
Nunziata V; Giannattasio R; di Giovanni G; Lettera AM; Nunziata CA
Clin Orthop Relat Res; 1993 Aug; (293):366-71. PubMed ID: 8339504
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of vitamin D metabolites in maternal and umbilical cord blood of Libyan and Norwegian women.
Markestad T; Elzouki A; Legnain M; Ulstein M; Aksnes L
Hum Nutr Clin Nutr; 1984 Jan; 38(1):55-62. PubMed ID: 6607243
[TBL] [Abstract][Full Text] [Related]
6. [The correlation between the serum levels of osteocalcin and 24,25-dihydroxyvitamin D in Paget's disease of bone].
Castro Errecarborde N; de la Piedra Gordo C; Rapado Errazti A
An Med Interna; 1990 Jun; 7(6):286-90. PubMed ID: 2102732
[TBL] [Abstract][Full Text] [Related]
7. Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone.
Devlin RD; Retallack RW; Fenton AJ; Grill V; Gutteridge DH; Kent GN; Prince RL; Worth GK
J Bone Miner Res; 1994 Jan; 9(1):81-5. PubMed ID: 8154313
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D metabolism in osteogenesis imperfecta during calcitonin therapy.
Nishi Y; Hyodo S; Yoshimitsu K; Sawano K; Yamaoka K; Seino Y; Usui T
Pediatrics; 1984 Apr; 73(4):538-42. PubMed ID: 6546792
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
Davoine GA; Jung A; Courvoisier B
Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
[TBL] [Abstract][Full Text] [Related]
10. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
Ralston SH; Boyce BF; Cowan RA; Fogelman I; Smith ML; Jenkins A; Boyle IT
J Bone Miner Res; 1987 Feb; 2(1):5-12. PubMed ID: 3137773
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of vitamin D metabolites in patients with hyperinsulinaemia.
Ishida H; Seino Y; Tsuda K; Matsukura S; Miyamoto Y; Ishizuka S; Imura H
Hum Nutr Clin Nutr; 1984 Nov; 38(6):473-5. PubMed ID: 6549179
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D.
Christiansen C; Christensen MS; McNair P; Nielsen B; Madsbad S
Scand J Clin Lab Invest; 1982 Oct; 42(6):487-91. PubMed ID: 6760373
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid function in Paget's disease of bone.
Siris ES; Clemens TP; McMahon D; Gordon A; Jacobs TP; Canfield RE
J Bone Miner Res; 1989 Feb; 4(1):75-9. PubMed ID: 2718781
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.
Charhon SA; Chapuy MC; Delvin EE; Meunier PJ
Miner Electrolyte Metab; 1985; 11(2):117-22. PubMed ID: 3838794
[TBL] [Abstract][Full Text] [Related]
15. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
[No Abstract] [Full Text] [Related]
16. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
Nuti R; Turchetti V; Righi G; Vattimo A
Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
[TBL] [Abstract][Full Text] [Related]
17. Abnormal vitamin D metabolism in Paget's disease of bone.
Guillard-Cumming DF; Beard DJ; Douglas DL; Johnson SK; Lawson-Matthew PJ; Russell RG; Kanis JA
Clin Endocrinol (Oxf); 1985 Apr; 22(4):559-66. PubMed ID: 3872746
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
[TBL] [Abstract][Full Text] [Related]
19. Parathormone, calcitonin, and vitamin D metabolites during normal fracture healing in geriatric patients.
Meller Y; Kestenbaum RS; Shany S; Galinsky D; Zuili I; Yankovitch N; Giat J; Conforti A; Torok G
Clin Orthop Relat Res; 1985 Oct; (199):272-9. PubMed ID: 4042489
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
Ghiringhelli G; Fogel M; Varela de RodrĂguez J; Casco C; MautelĂ©n C; Nusimovich B
Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
[No Abstract] [Full Text] [Related]
[Next] [New Search]